| Literature DB >> 34178047 |
Leandro Pablos Rossetti1, Larissa Bastos Eloy da Costa2, Ana Terezinha Guillaumon1.
Abstract
BACKGROUND: Renal ischemia-reperfusion (I/R) is directly associated with acute renal failure and can occur in conditions such as infarction caused by embolization or thrombosis, septicemia, and kidney transplantation. The process is complex, involving innate and adaptive immune responses, presence of cellular infiltrate, and production and release of cytokines and chemokines. It also triggers cell responses and release of reactive oxygen species, in addition to causing apoptosis and, in some cases, cell necrosis. Against this background, evaluation of renal tissue protection mechanisms is essential.Entities:
Keywords: ischemia-reperfusion; preservation solution; renal failure
Year: 2020 PMID: 34178047 PMCID: PMC8202179 DOI: 10.1590/1677-5449.190010
Source DB: PubMed Journal: J Vasc Bras ISSN: 1677-5449
Figure 1Composition of M&G solution.
Figure 2Presence of morphological changes providing evidence of the acute tubular necrosis process in group C. (A) acidophilia; (B) pyknotic nucleus; (C) loss of tubular framework.
Figure 3Immunohistochemical study of renal tissues. (A) control group marked with tumor necrosis factor (TNF); (B) Experimental group marked with TNF (there were differences in intensity of TNF expression, which was lower with the preservation solution); (C) Control group marked with vascular endothelial growth factor (VEGF); (D) Experimental group marked with VEGF (a trend was observed for reduced expression with use of the preservation solution).
Comparison of inflammatory markers and reaction intensity in three groups of rats: Sham (S), Control (C), and Experimental (E).
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| S | TNF | 6 | 11.05 | 12.19 | 0.00 | 0.00 | 9.75 | 13.70 | 33.10 | p = 0.002 → S≠E, S≠C |
| IL-8 | 6 | 59.78 | 29.05 | 22.80 | 34.20 | 64.45 | 85.00 | 87.80 | p = 0.268 | |
| VEGF | 6 | 29.82 | 13.19 | 12.40 | 18.90 | 30.15 | 39.50 | 47.80 | p = 0.038 → S≠C | |
| HIF | 6 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | p = 0.006 → S≠E, S≠C | |
| IntensTNF | 6 | 52.74 | 7.28 | 41.19 | 46.91 | 55.09 | 58.40 | 59.73 | p < 0.001 → S≠E, S≠C, E≠C | |
| IntensIL-8 | 6 | 52.20 | 7.84 | 41.92 | 47.95 | 51.02 | 56.70 | 64.60 | p = 0.003 → S≠E, S≠C | |
| IntensVEGF | 6 | 55.96 | 13.65 | 32.10 | 50.63 | 57.83 | 67.67 | 69.73 | p = 0.751 | |
| IntensHIF | 6 | 47.49 | 7.01 | 40.23 | 40.84 | 46.70 | 51.63 | 58.85 | p = 0.128 | |
| C | TNF | 6 | 94.55 | 9.58 | 76.50 | 90.80 | 100.00 | 100.00 | 100.00 | |
| IL-8 | 6 | 82.32 | 23.01 | 37.70 | 84.50 | 85.85 | 100.00 | 100.00 | ||
| VEGF | 6 | 47.25 | 10.66 | 37.10 | 39.60 | 42.90 | 60.10 | 60.90 | ||
| HIF | 6 | 15.97 | 8.90 | 0.90 | 10.70 | 19.05 | 22.50 | 23.60 | ||
| IntensTNF | 6 | 78.55 | 5.83 | 68.90 | 74.83 | 80.32 | 82.39 | 84.56 | ||
| IntensIL-8 | 6 | 76.50 | 5.18 | 69.48 | 72.18 | 77.28 | 80.24 | 82.56 | ||
| IntensVEGF | 6 | 54.85 | 7.93 | 42.81 | 48.18 | 56.57 | 61.51 | 63.48 | ||
| IntensHIF | 6 | 45.06 | 5.32 | 40.67 | 40.71 | 42.92 | 50.70 | 52.44 | ||
| E | TNF | 6 | 81.98 | 16.14 | 53.40 | 74.70 | 87.45 | 88.90 | 100.00 | |
| IL-8 | 6 | 82.63 | 14.93 | 67.00 | 70.00 | 79.40 | 100.00 | 100.00 | ||
| VEGF | 6 | 33.90 | 6.94 | 21.70 | 29.60 | 32.95 | 35.40 | 50.80 | ||
| HIF | 6 | 9.67 | 9.41 | 0.00 | 0.00 | 2.97 | 11.68 | 24.00 | ||
| IntensTNF | 6 | 67.46 | 4.12 | 60.37 | 65.35 | 68.29 | 71.08 | 71.36 | ||
| IntensIL-8 | 6 | 73.28 | 7.05 | 65.50 | 65.89 | 72.73 | 80.76 | 82.06 | ||
| IntensVEGF | 6 | 57.12 | 9.76 | 44.20 | 46.87 | 59.72 | 64.45 | 67.78 | ||
| IntensHIF | 6 | 53.87 | 6.96 | 48.60 | 49.71 | 51.08 | 55.51 | 67.23 |
SD = standard deviation; HIF = hypoxia-induced factor; IL-8 = interleukin 8; TNF = tumor necrosis factor; VEGF = vascular endothelial growth factor; IntensHIF = HIF Reaction intensity; IntensIL-8 = IL-8 Reaction intensity; IntensTNF = TNF Reaction intensity; IntensVEGF = VEGF Reaction intensity; N = number of rats in each group; Q1 = 25th percentile; Q3 = 75th percentile; Min = minimum value; Max = maximum value.
p values according to Kruskal-Wallis test to compare variables between the three groups.
Figura 1Composição da solução M&G.
Figura 2Presença de alterações morfológicas evidenciando processo de necrose tubular aguda no grupo C. (A) acidofilia; (B) núcleo picnótico; (C) perda do arcabouço tubular.
Figura 3Estudo da imuno-histoquímica do tecido renal. (A) grupo Controle marcado com fator de necrose tumoral (TNF); (B) grupo Estudo marcado com TNF (houve diferenças na intensidade de expressão do TNF, menor com a solução preservadora); (C) grupo Controle marcado com fator endotelial de crescimento vascular (VEGF); (D) grupo Estudo marcado com VEGF (evidenciou-se tendência de diminuição da expressão com o uso da solução preservadora).
Comparação dos marcadores inflamatórios e da intensidade de reação entre os três grupos de ratos: Sham (S), Controle (C) e Estudo (E).
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| S | TNF | 6 | 11,05 | 12,19 | 0,00 | 0,00 | 9,75 | 13,70 | 33,10 | p = 0,002 → S≠E, S≠C |
| IL-8 | 6 | 59,78 | 29,05 | 22,80 | 34,20 | 64,45 | 85,00 | 87,80 | p = 0,268 | |
| VEGF | 6 | 29,82 | 13,19 | 12,40 | 18,90 | 30,15 | 39,50 | 47,80 | p = 0,038 → S≠C | |
| HIF | 6 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | p = 0,006 → S≠E, S≠C | |
| IntensTNF | 6 | 52,74 | 7,28 | 41,19 | 46,91 | 55,09 | 58,40 | 59,73 | p < 0,001 → S≠E, S≠C, E≠C | |
| IntensIL-8 | 6 | 52,20 | 7,84 | 41,92 | 47,95 | 51,02 | 56,70 | 64,60 | p = 0,003 → S≠E, S≠C | |
| IntensVEGF | 6 | 55,96 | 13,65 | 32,10 | 50,63 | 57,83 | 67,67 | 69,73 | p = 0,751 | |
| IntensHIF | 6 | 47,49 | 7,01 | 40,23 | 40,84 | 46,70 | 51,63 | 58,85 | p = 0,128 | |
| C | TNF | 6 | 94,55 | 9,58 | 76,50 | 90,80 | 100,00 | 100,00 | 100,00 | |
| IL-8 | 6 | 82,32 | 23,01 | 37,70 | 84,50 | 85,85 | 100,00 | 100,00 | ||
| VEGF | 6 | 47,25 | 10,66 | 37,10 | 39,60 | 42,90 | 60,10 | 60,90 | ||
| HIF | 6 | 15,97 | 8,90 | 0,90 | 10,70 | 19,05 | 22,50 | 23,60 | ||
| IntensTNF | 6 | 78,55 | 5,83 | 68,90 | 74,83 | 80,32 | 82,39 | 84,56 | ||
| IntensIL-8 | 6 | 76,50 | 5,18 | 69,48 | 72,18 | 77,28 | 80,24 | 82,56 | ||
| IntensVEGF | 6 | 54,85 | 7,93 | 42,81 | 48,18 | 56,57 | 61,51 | 63,48 | ||
| IntensHIF | 6 | 45,06 | 5,32 | 40,67 | 40,71 | 42,92 | 50,70 | 52,44 | ||
| E | TNF | 6 | 81,98 | 16,14 | 53,40 | 74,70 | 87,45 | 88,90 | 100,00 | |
| IL-8 | 6 | 82,63 | 14,93 | 67,00 | 70,00 | 79,40 | 100,00 | 100,00 | ||
| VEGF | 6 | 33,90 | 6,94 | 21,70 | 29,60 | 32,95 | 35,40 | 50,80 | ||
| HIF | 6 | 9,67 | 9,41 | 0,00 | 0,00 | 2,97 | 11,68 | 24,00 | ||
| IntensTNF | 6 | 67,46 | 4,12 | 60,37 | 65,35 | 68,29 | 71,08 | 71,36 | ||
| IntensIL-8 | 6 | 73,28 | 7,05 | 65,50 | 65,89 | 72,73 | 80,76 | 82,06 | ||
| IntensVEGF | 6 | 57,12 | 9,76 | 44,20 | 46,87 | 59,72 | 64,45 | 67,78 | ||
| IntensHIF | 6 | 53,87 | 6,96 | 48,60 | 49,71 | 51,08 | 55,51 | 67,23 |
DP = desvio padrão; HIF = fator induzido pela hipóxia; IL-8 = interleucina 8; TNF = fator de necrose tumoral; VEGF = fator endotelial de crescimento vascular; IntensHIF = Intensidade do HIF; IntensIL-8 = Intensidade da IL-8; IntensTNF = Intensidade do TNF; IntensVEGF = Intensidade do VEGF; N = número de ratos de cada grupo; Q1 = percentil 25; Q3 = percentil 75; Min = valor mínimo; Máx = valor máximo.
Valor de p referente ao teste de Kruskal-Wallis para comparação das variáveis entre os três grupos.